Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Aquestive Therapeutics, Inc. (AQST)

3.8900 -0.1500 (-3.71%)
At close: October 30 at 4:00:01 PM EDT
3.9453 +0.0553 (+1.42%)
After hours: October 30 at 7:43:59 PM EDT
Trade AQST on Coinbase

News headlines

Updated 40m ago
Powered by Yahoo Scout

Aquestive Therapeutics has secured an FDA review date for Anaphylm and added a U.S. licensing agreement for LIBERVANT. The company’s next major catalyst is its third-quarter 2026 results on November 3, followed by an investor call on November 4.

Mobilize your Website
View Site in Mobile | Classic
Share by: